Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael D. Katz is active.

Publication


Featured researches published by Michael D. Katz.


Journal of Vascular and Interventional Radiology | 2004

N-butyl cyanoacrylate embolization for control of acute arterial hemorrhage.

John William Kish; Michael D. Katz; M. Victoria Marx; Donald S. Harrell; Sue E. Hanks

PURPOSE To report the initial clinical experience with the use of n-butyl cyanoacrylate (NBCA) for embolization of acute arterial hemorrhage from varied etiologies and at varied anatomic sites. MATERIALS AND METHODS Sixteen patients who demonstrated active extravasation of contrast material and/or arterial abnormality underwent NBCA embolization. Sites of embolization included the gastrointestinal tract, kidney, liver, uterus, adrenal gland, extremity, and chest wall. Standard coil or particulate embolization had previously failed in 10 patients. NBCA was used as the initial embolic agent in the remaining six patients. After treatment, serial hematocrit levels, transfusion requirements, and clinical signs and symptoms were monitored for stabilization. Patients were evaluated for signs and symptoms of end-organ damage. RESULTS NBCA embolization was successful in 12 of 16 patients (75%), who exhibited complete cessation of bleeding. In four patients (25%), NBCA embolization was of no benefit. Embolization failed in two of 16 patients (12.5%), who showed evidence of recurrent bleeding after use of NBCA. The remaining two patients (12.5%) died within 24 hours of the procedure. None of the 16 patients developed clinical signs of end-organ damage or iatrogenic ischemia attributable to NBCA. CONCLUSIONS In this initial limited series, NBCA embolization was shown to be a feasible and effective method to control acute arterial hemorrhage. NBCA embolization was able to stop arterial bleeding even when previous coil or particulate embolization had failed.


Radiographics | 2009

Thermal Ablation of Osteoid Osteoma: Overview and Step-by-Step Guide

Daria Motamedi; Thomas J. Learch; David N. Ishimitsu; Kambiz Motamedi; Michael D. Katz; Earl W. Brien; Lawrence R. Menendez

Osteoid osteoma is a small, benign but painful lesion with specific clinical and imaging characteristics. Computed tomography is the imaging modality of choice for visualization of the nidus and for treatment planning. Complete surgical excision of the nidus is curative, providing symptomatic relief, and is the traditionally preferred treatment. However, surgery has disadvantages, including the difficulty of locating the lesion intraoperatively, the need for prolonged hospitalization, and the possibility of postoperative complications ranging from an unsatisfactory cosmetic result to a fracture. Percutaneous radiofrequency (RF) ablation, which involves the use of thermal coagulation to induce necrosis in the lesion, is a minimally invasive alternative to surgical treatment of osteoid osteoma. With reported success rates approaching 90%, RF ablation should be considered among the primary options available for treating this condition.


Journal of Vascular and Interventional Radiology | 1993

Effectiveness of Transcatheter Embolization in the Control of Hepatic Vascular Injuries

Richard A. Schwartz; George P. Teitelbaum; Michael D. Katz; Michael J. Pentecost

PURPOSE The authors describe their 11-year experience with transcatheter embolization (TCE) in the treatment of patients with hemorrhagic hepatic injuries. PATIENTS AND METHODS Twenty-eight TCE procedures were performed in 24 patients between 1980 and 1991. Injuries in 21 patients were due to vehicular or criminal trauma; in three patients, injuries were iatrogenic. There were 21 male and three female patients (age range, 6-64 years). All patients underwent angiography and had evidence of active hemorrhage, pseudoaneurysm, or arteriovenous fistula (AVF). All embolizations were performed with use of Gianturco coils, microcoils, or gelatin sponge. RESULTS TCE was technically successful in occluding hepatic vascular lesions in 21 of 24 patients (88%). Technical failures were due to the inability to select the appropriate vessel for embolization in two cases and due to a persistent AVF that did not occlude despite further attempts at embolization. Lesions recurred in two patients who underwent initially successful TCE. Both patients were treated effectively with repeated TCE. Only two catheter-related complications were encountered, both after successful TCE. Twenty-one patients survived to be discharged from the hospital. Two patients among the group treated successfully and one from the group in whom treatment failed died. CONCLUSION This experience demonstrates that TCE is effective in the management of hepatic vascular injuries due to trauma.


Journal of Vascular and Interventional Radiology | 1993

Microcatheter Embolization of Non-neurologic Traumatic Vascular Lesions

George P. Teitelbaum; Richard A. Reed; Donald W. Larsen; Raymond K. Lee; Michael J. Pentecost; Ethel J. Finck; Michael D. Katz

PURPOSE The authors report their experience over a 28-month period with embolization of 23 non-neurologic traumatic vascular lesions in 21 patients with use of a coaxial microcatheter coil delivery system. PATIENTS AND METHODS The injuries included pseudoaneurysms (n = 17), arteriovenous fistulas (n = 3), and sites of extravasation (n = 3) and were caused by gunshot, shotgun, and stab wounds, as well as motor vehicle accidents and iatrogenic trauma. All microcatheter embolizations except one were performed with 2.2-F Tracker-18 catheters inserted coaxially through 5.0-5.5-F guiding catheters. In one case, a coaxial 3-F Teflon catheter was used. In all cases platinum microcoils (almost all non-fibril) and/or straight platinum embolization wires (with fibrils) were used. RESULTS Twenty-one (91%) of 23 vascular lesions were successfully occluded with use of the microcatheter system. The two cases in which microcatheter embolization failed were successfully managed by using larger catheters and steel coils. Two patients with hepatic vascular lesions (one site of extravasation and a pseudoaneurysm) and one patient with a lower extremity arteriovenous fistula required two procedures each for successful treatment. Procedures were life-saving in at least two patients. Two lesions recurred during follow-up ranging from 3 days to 17 months. Both of these recurrences were successfully treated with transcatheter embolization, in one case with use of microcatheters. CONCLUSION Microcatheter embolization with platinum coils and wires is an effective means for treating traumatic vascular lesions. A coaxial microcatheter system allows for easier, more rapid coil/wire delivery to smaller, spasm-prone arteries in such cases.


Journal of Vascular and Interventional Radiology | 1994

Prevalence of Infection Following Hepatic Chemoembolization with Cross-linked Collagen with Administration of Prophylactic Antibiotics

Richard A. Reed; George P. Teitelbaum; John R. Daniels; Michael J. Pentecost; Michael D. Katz

PURPOSE The authors present their experience with 494 hepatic chemoembolization (HCE) procedures in 236 patients with administration of a mixture of cross-linked collagen and chemotherapeutic agents. The prevalence of infectious complications was compared in patients who did and did not receive prophylactic administration of antibiotics as part of the HCE procedure. PATIENTS AND METHODS Fourteen HCE procedures in nine patients were performed without prophylactic antibiotics (PA). These patients underwent embolization with cross-linked collagen alone or with low-dose cisplatinum. All of the remaining 480 procedures in 227 patients were performed with PA. RESULTS One of the nine patients (11%) who did not receive PA experienced fatal sepsis within 24 hours of HCE. Of the 227 patients who did receive antibiotics, six (2.6%) developed hepatic abscess and no fatal sepsis was encountered. CONCLUSION Use of PA decreases the prevalence of infectious complications following HCE.


Radiographics | 2012

Beyond Hemostasis: Spectrum of Gynecologic and Obstetric Indications for Transcatheter Embolization

Michael D. Katz; Sebastian B. Sugay; Daphne K. Walker; Suzanne Palmer; M. Victoria Marx

Percutaneous vascular embolization is a useful therapeutic option for a wide range of gynecologic and obstetric abnormalities. Transcatheter embolization procedures performed with the use of radiologic imaging for guidance are minimally invasive and may obviate surgery, thereby decreasing morbidity and mortality and safeguarding the patients future fertility potential. To integrate this treatment method optimally into patient care, knowledge is needed about the clinical indications for therapeutic embolization, the relevant vascular anatomy, technical considerations of the procedure, and the potential risks and benefits of embolization. The most well-known and well-studied transcatheter embolization technique for treating a gynecologic-obstetric condition is uterine fibroid embolization. However, the clinical indications for transcatheter embolization are much broader and include many benign gynecologic conditions, such as adenomyosis and arteriovenous malformations, as well as intractable bleeding due to inoperable advanced-stage malignancies. Uterine artery embolization may be performed to prevent or treat bleeding associated with various obstetric conditions, including postpartum hemorrhage, placental implantation abnormality, and ectopic pregnancy. Embolization of the uterine artery or the internal iliac artery also may be performed to control pelvic bleeding due to coagulopathy or iatrogenic injury, and ovarian vein embolization has been shown to be effective for the management of pelvic congestion syndrome. The article discusses these and other gynecologic and obstetric indications for transcatheter embolization, provides detailed descriptions of imaging findings before and after embolization, and reviews procedural techniques and outcomes.


CardioVascular and Interventional Radiology | 1998

Gastrointestinal Hemorrhage Due to Duodenal Erosion by a Biliary Wallstent

Derek J. Roebuck; Philip Stanley; Michael D. Katz; Robert L. Parry; Michael A. Haight

A self-expanding metallic stent (Wallstent) was used to relieve obstruction of the common bile duct in a young male with a desmoplastic small cell tumor of the abdomen. Two months after insertion and following a course of chemotherapy the lower end of the stent eroded the mucosa of the second part of the duodenum causing severe gastrointestinal hemorrhage which necessitated laparotomy and trimming of the stent. This complication may have been due to shrinking of the tumor as well as thrombocytopenia following chemotherapy.


Journal of Vascular and Interventional Radiology | 1996

Admixture of Heparin with Urokinase to Decrease Thrombolysis Time and Urokinase Dose in Polytetrafluoroethylene Dialysis Graft Recanalization

Donald S. Harrell; Mark Kozlowski; Michael D. Katz; Sue E. Hanks

PURPOSE To determine whether the addition of heparin to urokinase during dialysis graft thrombolysis can lower urokinase dose and shorten procedure time. PATIENTS AND METHODS Patients who underwent dialysis graft thrombolysis during an 18-month period were studied retrospectively. Twenty patients were treated with urokinase alone, and 19 patients were treated with urokinase and heparin. Thrombolysis was performed in the angiography suite by using a crossed-catheter technique. Urokinase was administered directly into the thrombus. In patients receiving heparin, 5,000 IU was added directly to the initial urokinase solution. RESULTS In patients who received urokinase alone, an average of 750,000 U of urokinase was used, and the average procedure time was 2 hours 42 minutes. When heparin was added, an average of 435,000 U of urokinase was used, and the average procedure time was 2 hours. CONCLUSION The addition of heparin to urokinase can decrease both urokinase dose and thrombolysis time in the recanalization of dialysis grafts.


Abdominal Radiology | 2017

Intra-arterial contrast-enhanced ultrasound (IA CEUS) for localization of hepatocellular carcinoma (HCC) supply during transarterial chemoembolization (TACE): a case series

Ilya Lekht; Megha Nayyar; Brian Luu; Phillip L. Guichet; Jessica Y Ho; R. Ter-Oganesyan; Michael D. Katz; Mittul Gulati

Transarterial chemoembolization (TACE) is a proven catheter-based locoregional therapy for treatment of hepatocellular carcinoma (HCC). Drug-eluting bead TACE involves delivering micrometer-sized particles preloaded with doxorubicin directly to the tumor via its arterial blood supply and results in vascular embolization with intra-tumoral drug release. Effective therapy requires mapping of the tumor arterial supply, which in some cases cannot be accomplished with conventional angiographic techniques alone. Contrast-enhanced ultrasound (CEUS) is an imaging technique which utilizes microbubble contrast agents to demonstrate blood flow and tissue perfusion, enabling tumor visualization in real time. CEUS with intravenous contrast administration is well established for evaluation of HCC. Intra-arterial (IA) CEUS, on the other hand, is an emerging technique that allows more selective evaluation of the arterial supply to the tumor. The three cases in this report illustrate the utility of intra-procedural IA CEUS during TACE. Specifically, IA CEUS aided TACE in cases where the HCC showed poor arterial enhancement, an extrahepatic arterial supply, and a portal venous supply, respectively.


CardioVascular and Interventional Radiology | 1993

Bird's Nest filter placement within an enlarged hemiazygos vein for prevention of pulmonary embolism

George P. Teitelbaum; Robert H. McKay; Michael D. Katz

Thrombosis of the inferior vena cava (IVC) may result in considerable enlargement of paravertebral, azygos, and hemiazygos collateral veins that may in turn serve as pathways for thromboemboli to the pulmonary circulation. Herein we describe the transfemoral placement of a Birds Nest filter within an enlarged hemiazygos vein to provide prophylaxis against pulmonary embolism in a patient with right femoral venous thrombosis who could not tolerate systemic anticoagulation. There had been earlier transjugular placement of a Greenfield filter within the suprarenal IVC.

Collaboration


Dive into the Michael D. Katz's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sue E. Hanks

University of Southern California

View shared research outputs
Top Co-Authors

Avatar

Donald S. Harrell

University of Southern California

View shared research outputs
Top Co-Authors

Avatar

Ilya Lekht

University of Southern California

View shared research outputs
Top Co-Authors

Avatar

Megha Nayyar

University of Southern California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mittul Gulati

University of Southern California

View shared research outputs
Top Co-Authors

Avatar

R. Ter-Oganesyan

University of Southern California

View shared research outputs
Top Co-Authors

Avatar

Suzanne Palmer

University of Southern California

View shared research outputs
Top Co-Authors

Avatar

David B. Sacks

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge